ESLG 0238 (T&F: 3:25-5:05) SITU SUIYAN (SUSAN) Diversity Plan of Johnson and Johnson I. Overview of company Johnson and Johnson company has a long history‚ which was founded in 1886 by Robert Wood Johnson‚ James Wood Johnson and Edward Mead Johnson in Brunsewick‚ New Jersey. Until now‚ Johnson and Johnson has 250 branches in over 57 countries‚ and it has nearly a hundred consumer brands with thousands of products sold in over 157 countries. The products are including medication‚ first aid
Premium Discrimination Johnson & Johnson
the organizational goals F. Analyses (4-4 pages for a & b) a. Five Force Analysis of resources i. The threat of new entrants ii. The bargaining power of buyers iii. The bargaining power of suppliers iv. The threat of substitute products and services v. The intensity of rivalry among competitors in the industry vi. Evaluation of resources: 1. Are they rare? 2. Are they valuable? 3. Are they difficult to imitate? 4. Are they difficult to substitute? b. Financial analysis i. Short-term
Premium Term Time
product (mothers generally don’t want their teenage daughters to wear “makeup”) - The target audience can be confused of the product’s purpose (Cosmetic? Toiletry?) 2) Johnson’s Face Powder as Cosmetic • Distribution channel: department stores • Case: Dark color (e.g black) with gold lettering • Promote on TV and fashion magazine as a new line of cosmetic product + Appeal more to teens and young female adults as “cosmetic” product + Enhance the brand image as more - May encounter resistance
Premium Cosmetics Marketing
The $10‚000 investment made into Johnson and Johnson is a good investment to have in your portfolio. This is because of the stable nature of Johnson and Johnson and the growth trend of the company. Based on the JNJ 10-Ks for the last 5 years ended Jan. 1‚ 2012‚ the revenue trend is growing. Revenues have trended favorably from $61‚095 in the year ended Jan. 2007 to $65‚030 in the year ended Jan. 1‚ 2012. The company is also operating efficiently showing the more stable aspect of this investment
Premium Investment Asset Financial ratios
PSYCHOLOGICAL REPORT Student ID #: 22923629 Client Name: Sandra Johnson Date of Report: 09/23/10 REFERRAL QUESTION/ REASON FOR TESTING Sandra Johnson was referred the Chief of Staff of Greenrun Medical Center for evaluation after her work performance and interpersonal relations substantially decreased after being assigned to a nursing missionary stationed in Rwanda. As the head nurse for the missionary Sandra will be stationed in Rwanda with 20 subordinates for a period of
Premium Psychology Management Sociology
Case Analysis China Dolls Issues : the company is about to lose two major customers due to “cheaper” price‚ namely China. Alternatives: 1. Move to China Closing down partially Malaysian and Chieng Mai operations 2. Expand to China Retain Malaysian operations Joint venture 3. Develop own label for Malaysian and ASEAN market. Costs : i. Set-up costs (investment) ii. Operation costs (labor cost) iii. Sunk costs iv. Opportunity costs v. Human ‘cost’ Explanations
Premium Costs
ANALYSIS OF THE MARKETING MIX OF JOHNSON & JOHNSON I. Introduction The case took into consideration the situation surrounding the handling of Johnson & Johnson under William Weldon. Based on the case study‚ Weldon was a master of marketing‚ which was then to the advantage of the monolith J&J. The following discussions will analyze the capability of J&J using the marketing mix to maximize the profits gained by the said company under the headship of Weldon. II.
Premium Marketing Promotion
Steven-Johnson Syndrome: Pathogenesis‚ Diagnosis‚ and Management Traci Segar Winona State University Steven-Johnson Syndrome: Pathogenesis‚ Diagnosis‚ and Management In 1976 I was diagnosed with Steven-Johnson Syndrome. I was two weeks shy of my third birthday. I developed a sore throat and was given my first penicillin injection. My parents tell me that‚ several days later‚ I spiked a fever and complained that my arms and legs hurt. I was refusing to move and didn’t want to eat anything
Premium Medicine Symptoms Infection
The Johnson & Johnson Tylenol Incident In 1982 Johnson and Johnson‚ the pharmaceutical company that makes Tylenol announced a nationwide recall of Tylenol; 31 million bottles and a loss of 100 million dollars. This recall was secondary to the death of seven people in the Chicago area after using Tylenol. An investigation reveled the poisoning were found to be that of an outside source. The Tylenol was contaminated with cyanide from an outside source. Johnson and Johnson ’s response to the poisonings
Premium Tylenol Johnson & Johnson Pharmacology
Technique analysis Firstly‚ Johnson & Johnson Pharmaceutical uses focused differentiation technique in marketing its new proprietary medicines (Saylor 5‚ 2013). In 2013‚ it came up with three major medicines: INVOKANA (canagliflozin)‚ IMBRUVICA (ibrutinib) and OLYSIO (simeprevir) (Johnson & Johnson [J&J]‚ 2013). Each medicine has its own focused market: INVOKANA for Type 2 diabetic patients‚ which affects approximately 26 million people in the United States; IMBRUVICA for people with the rare mantle
Premium Blood sugar Blood sugar Health care